Atossa Therapeutics
ATOS
#10757
Rank
โ‚ฌ17.52 M
Marketcap
1,76ย โ‚ฌ
Share price
-1.53%
Change (1 day)
158.20%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: โ‚ฌ17.52 Million

As of November 2026 Atossa Therapeutics has a market cap of โ‚ฌ17.52 Million. This makes Atossa Therapeutics the world's 10757th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ17.52 M-75.81%
2025โ‚ฌ72.45 M-38.91%
2024โ‚ฌ0.11 B18.91%
2023โ‚ฌ99.74 M59.89%
2022โ‚ฌ62.38 M-65.13%
2021โ‚ฌ0.17 B387.12%
2020โ‚ฌ36.72 M186.98%
2019โ‚ฌ12.79 M145.49%
2018โ‚ฌ5.21 M-25.27%
2017โ‚ฌ6.97 M37.37%
2016โ‚ฌ5.07 M-46.87%
2015โ‚ฌ9.55 M-66.91%
2014โ‚ฌ28.88 M-7.44%
2013โ‚ฌ31.2 M-18.08%
2012โ‚ฌ38.09 M

End of Day market cap according to different sources

On Nov 16th, 2026 the market cap of Atossa Therapeutics was reported to be:

โ‚ฌ17.52 Million
by Nasdaq info icon info icon
โ‚ฌ17.52 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ618.90 B 3,531,488.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ26.24 B 149,682.11%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ27.51 B 156,928.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ2.56 B 14,562.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
โ‚ฌ1.81 B 10,252.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
โ‚ฌ33.29 M 89.97%๐Ÿ‡บ๐Ÿ‡ธ USA